The Regionalization of Medical Management: The Practice and Exploration of Established Fudan-Minhang Medical Alliance

Autor: Meirong Ling, Manar M. Atyah, Ning Ren

Publikováno v: Translational Bioinformatics ISBN: 9789811678929

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::22e4ef8524a337b48f28236db6f062d0
https://doi.org/10.1007/978-981-16-7893-6_9

Impact of Frailty on Short-Term Outcomes of Hepatic Lobectomy in Patients with Intrahepatic Cholangiocarcinoma: Evidence from the US Nationwide Inpatient Sample 2005-2018.

Autor: Xu L; Department of Hepatobiliary and Pancreatic Surgery, China-Japan Friendship Hospital, Beijing, China., Shao Z; Department of Clinical Laboratory, China-Japan Friendship Hospital, Beijing, China., Huang H; Department of Hepatobiliary and Pancreatic Surgery, China-Japan Friendship Hospital, Beijing, China.; Graduate School, Peking Union Medical College, Beijing, China., Li D, Wang T; Department of Hepatobiliary and Pancreatic Surgery, China-Japan Friendship Hospital, Beijing, China.; Graduate School, Peking University Health Science Center, Beijing, China., Atyah M; Department of Hepatobiliary and Pancreatic Surgery, China-Japan Friendship Hospital, Beijing, China., Zhou W; Department of Hepatobiliary and Pancreatic Surgery, China-Japan Friendship Hospital, Beijing, China., Yang Z; Department of Hepatobiliary and Pancreatic Surgery, China-Japan Friendship Hospital, Beijing, China.

Publikováno v: Digestive surgery [Dig Surg] 2024; Vol. 41 (1), pp. 42-52. Date of Electronic Publication: 2024 Jan 31.

GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism.

Autor: Zhou Q; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, China., Yin Y; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, China; Department of Liver Surgery, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China., Yu M; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, China., Gao D; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, China., Sun J; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, China., Yang Z; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, China., Weng J; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, China., Chen W; Institute of Fudan Minhang Academic Health System (AHS), Key Laboratory of Whole-period Monitoring and Precise Intervention of Digestive Cancer (SMHC), Minhang Hospital & AHS, Fudan University, Shanghai, China., Atyah M; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, China., Shen Y; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, China., Ye Q; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, China., Li CW; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hung MC; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States; Graduate Institute of Biomedical Sciences and Center for Molecular Medicine, China Medical University, Taichung, Taiwan., Dong Q; Institute of Fudan Minhang Academic Health System (AHS), Key Laboratory of Whole-period Monitoring and Precise Intervention of Digestive Cancer (SMHC), Minhang Hospital & AHS, Fudan University, Shanghai, China. Electronic address: qzhdong@fudan.edu.cn., Zhou C; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, China; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address: zhouchenhao@fudan.edu.cn., Ren N; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, China; Institute of Fudan Minhang Academic Health System (AHS), Key Laboratory of Whole-period Monitoring and Precise Intervention of Digestive Cancer (SMHC), Minhang Hospital & AHS, Fudan University, Shanghai, China. Electronic address: ren.ning@zs-hospital.sh.cn.

Publikováno v: Redox biology [Redox Biol] 2022 Oct; Vol. 56, pp. 102458. Date of Electronic Publication: 2022 Sep 10.

Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma.

Autor: Weng J; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, People's Republic of China., Zhou C; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, People's Republic of China.; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhou Q; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, People's Republic of China., Chen W; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, People's Republic of China.; Institute of Fudan Minhang Academic Health System, Minhang Hospital, Key Laboratory of Shanghai Municipal Health Commission, Fudan University, Shanghai, People's Republic of China., Yin Y; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, People's Republic of China., Atyah M; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, People's Republic of China., Dong Q; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Institute of Fudan Minhang Academic Health System, Minhang Hospital, Key Laboratory of Shanghai Municipal Health Commission, Fudan University, Shanghai, People's Republic of China.; Institutes of Biomedical Sciences, Fudan University, Shanghai, People's Republic of China., Shi Y; Biomedical Research Centre, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China., Ren N; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, People's Republic of China.; Institute of Fudan Minhang Academic Health System, Minhang Hospital, Key Laboratory of Shanghai Municipal Health Commission, Fudan University, Shanghai, People's Republic of China.

Publikováno v: Journal of hepatocellular carcinoma [J Hepatocell Carcinoma] 2021 Mar 29; Vol. 8, pp. 193-209. Date of Electronic Publication: 2021 Mar 29 (Print Publication: 2021).

High RPS3A expression correlates with low tumor immune cell infiltration and unfavorable prognosis in hepatocellular carcinoma patients.

Autor: Zhou C; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University Shanghai 200032, China.; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, TX 77030, USA., Weng J; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University Shanghai 200032, China., Liu C; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, TX 77030, USA., Zhou Q; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University Shanghai 200032, China., Chen W; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University Shanghai 200032, China.; Institute of Fudan Minhang Academic Health System, Key Laboratory of Whole-Period Monitoring and Precise Intervention of Digestive Cancer (SMHC), Minhang Hospital & AHS, Fudan University Shanghai 200032, China., Hsu JL; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, TX 77030, USA., Sun J; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University Shanghai 200032, China., Atyah M; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University Shanghai 200032, China., Xu Y; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University Shanghai 200032, China., Shi Y; Biomedical Research Centre, Zhongshan Hospital, Fudan University Shanghai 200032, China., Shen Y; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University Shanghai 200032, China., Dong Q; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, TX 77030, USA.; Institute of Fudan Minhang Academic Health System, Key Laboratory of Whole-Period Monitoring and Precise Intervention of Digestive Cancer (SMHC), Minhang Hospital & AHS, Fudan University Shanghai 200032, China.; Institutes of Biomedical Sciences, Fudan University Shanghai 200032, China., Hung MC; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, TX 77030, USA.; Graduate Institute of Biomedical Sciences and Center for Molecular Medicine, China Medical University Taichung 40402, Taiwan., Ren N; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University Shanghai 200032, China.; Institute of Fudan Minhang Academic Health System, Key Laboratory of Whole-Period Monitoring and Precise Intervention of Digestive Cancer (SMHC), Minhang Hospital & AHS, Fudan University Shanghai 200032, China.

Publikováno v: American journal of cancer research [Am J Cancer Res] 2020 Sep 01; Vol. 10 (9), pp. 2768-2784. Date of Electronic Publication: 2020 Sep 01 (Print Publication: 2020).